Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Dow Futures Rise 115 Pts; Fed's Favorite Inflation Gauge Due

Published 09/30/2022, 07:20 PM
Updated 09/30/2022, 07:20 PM
© Reuters

© Reuters

By Peter Nurse

Investing.com -- U.S. stocks are seen opening higher Friday, bouncing from the previous session's sharp losses ahead of key inflation data with a difficult month drawing to a close.

At 07:00 ET (11:00 GMT), the Dow Futures contract was up 115 points or 0.4%, S&P 500 Futures traded 20 points or 0.5% higher, and Nasdaq 100 Futures climbed 55 points or 0.5%.

The main equity indices posted hefty losses Thursday, with the blue-chip Dow Jones Industrial Average ending over 450 points or 1.5% lower, the broad-based S&P 500 dropping 2.1%, and the tech-heavy Nasdaq Composite falling 2.8%.

These losses sum up a troublesome month for investors, as aggressive actions by the Federal Reserve to tame inflation have prompted concerns that the U.S. economy will slump into recession.

For September, the Dow is off 7.3%, the S&P 500 is down 8%, and the Nasdaq Composite is on track for a loss of 9.1% for the month.

There are more speeches from Fed policymakers later Friday, and their comments will be studied carefully for their views on the future path of interest rates.

The U.S. central bank last week delivered a third-straight 75-basis-point interest rate increase, lifting its policy rate target range to 3%-3.25%, and expectations are rife that the policymakers will agree to another such hike in November.

Ahead of that, the Fed's preferred inflation measure, the core PCE price index, is due at 08:30 ET (12:30 GMT) and is expected to have risen 0.5% in August, compared with 0.1% the prior month. The year-over-year expectation is a gain of 4.7% compared with 4.6% the prior month.

In Europe, inflation climbed to a fresh record high in September, with the year-on-year reading at 10%, up from 9.1% in August and above economists' estimates of 9.7%.

In the corporate sector, Nike (NYSE:NKE) stock fell over 10% premarket after the world's largest sportswear maker cautioned that gross margins would remain under pressure through the year.

Amylyx Pharmaceuticals (NASDAQ:AMLX) rose over 9% premarket after the U.S. Food and Drug Administration approved its drug to treat a fatal neurodegenerative condition commonly known as Lou Gehrig's disease.

Oil prices rose Friday, but are heading for the first quarterly drop in two years on continued fears over a global economic slowdown.

Next week sees the latest get-together of the Organization of the Petroleum Exporting Countries and allies, together called OPEC+, amid speculation that the group will agree to cut crude output in order to support falling prices.

By 07:00 ET, U.S. crude futures traded 0.4% higher at $81.59 a barrel, while the Brent contract rose 0.4% to $87.53.

Additionally, gold futures rose 0.4% to $1,674.75/oz, while EUR/USD traded 0.5% lower at 0.9765.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.